Cargando…

Allosteric inhibitors of the main protease of SARS-CoV-2

SARS-CoV-2 has raised the alarm to search for effective therapy for this virus. To date several vaccines have been approved but few available drugs reported recently still need approval from FDA. Remdesivir was approved for emergency use only. In this report, the SARS-CoV-2 3CLpro was expressed and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Samrat, Subodh Kumar, Xu, Jimin, Xie, Xuping, Gianti, Eleonora, Chen, Haiying, Zou, Jing, Pattis, Jason G., Elokely, Khaled, Lee, Hyun, Li, Zhong, Klein, Michael L., Shi, Pei-Yong, Zhou, Jia, Li, Hongmin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272661/ https://www.ncbi.nlm.nih.gov/pubmed/35835291 http://dx.doi.org/10.1016/j.antiviral.2022.105381

Ejemplares similares

Antiviral Agents against Flavivirus Protease: Prospect and Future Direction
por: Samrat, Subodh K., et al.
Publicado: (2022)

The main protease of SARS-CoV-2 downregulates innate immunity via a translational repression
por: Liang, Weifeng, et al.
Publicado: (2023)

Allosteric Hotspots in the Main Protease of SARS-CoV-2
por: Strömich, Léonie, et al.
Publicado: (2022)

An extended conformation of SARS-CoV-2 main protease reveals allosteric targets
por: Sun, Zengchao, et al.
Publicado: (2022)

X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease
por: Günther, Sebastian, et al.
Publicado: (2021)

Prospect of SARS-CoV-2 spike protein: Potential role in vaccine and therapeutic development
por: Samrat, Subodh Kumar, et al.
Publicado: (2020)

Allosteric Inhibitors of the NS3 Protease from the Hepatitis C Virus
por: Abian, Olga, et al.
Publicado: (2013)

Allosteric Site Inhibitor Disrupting Auto-Processing of Malarial Cysteine Proteases
por: Pant, A., et al.
Publicado: (2018)

Structural Basis for the Inhibition of Coronaviral Main Proteases by a Benzothiazole-Based Inhibitor
por: Hu, Xiaohui, et al.
Publicado: (2022)

Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases
por: Yang, Haitao, et al.
Publicado: (2005)

Allosteric Inhibition of the SARS‐CoV‐2 Main Protease: Insights from Mass Spectrometry Based Assays
por: El‐Baba, Tarick J., et al.
Publicado: (2020)

Factual insights of the allosteric inhibition mechanism of SARS-CoV-2 main protease by quercetin: an in silico analysis
por: Verma, Shalja, et al.
Publicado: (2021)

A conformational switch high-throughput screening assay and allosteric inhibition of the flavivirus NS2B-NS3 protease
por: Brecher, Matthew, et al.
Publicado: (2017)

The Discovery of Small Allosteric and Active Site Inhibitors of the SARS-CoV-2 Main Protease via Structure-Based Virtual Screening and Biological Evaluation
por: Mahgoub, Radwa E., et al.
Publicado: (2022)

Benserazide, the first allosteric inhibitor of Coxsackievirus B3 3C protease()
por: Kim, Bo-Kyoung, et al.
Publicado: (2015)

1-Piperidine Propionic Acid as an Allosteric Inhibitor of Protease Activated Receptor-2
por: Chinellato, Monica, et al.
Publicado: (2023)

Individual and common inhibitors of coronavirus and picornavirus main proteases
por: Kuo, Chih-Jung, et al.
Publicado: (2009)

Action of Dipeptidyl Peptidase‐4 Inhibitors on SARS‐CoV‐2 Main Protease
por: Nar, Herbert, et al.
Publicado: (2021)

Xanthohumol Is a Potent Pan-Inhibitor of Coronaviruses Targeting Main Protease
por: Lin, Yuxi, et al.
Publicado: (2021)

Correction: Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases
por: Yang, Haitao, et al.
Publicado: (2005)

Allosteric Inhibitors of Zika Virus NS2B-NS3 Protease Targeting Protease in “Super-Open” Conformation
por: Meewan, Ittipat, et al.
Publicado: (2023)

Triple-action inhibitory mechanism of allosteric TYK2-specific inhibitors
por: Wang, Jimin, et al.
Publicado: (2023)

Mechanism of the allosteric activation of the ClpP protease machinery by substrates and active-site inhibitors
por: Felix, Jan, et al.
Publicado: (2019)

Broad-Spectrum Allosteric Inhibition of Herpesvirus Proteases
por: Gable, Jonathan E., et al.
Publicado: (2014)

An Allosteric Modulator of HIV-1 Protease Shows Equipotent Inhibition of Wild-Type and Drug-Resistant Proteases
por: Ung, Peter M.-U., et al.
Publicado: (2014)

Potential SARS-CoV-2 main protease inhibitors
por: Banerjee, Riddhidev, et al.
Publicado: (2021)

Developing inhibitors of the SARS-CoV-2 main protease
por: Seitz, Christian, et al.
Publicado: (2022)

Allosteric Modulation of the Main Protease (M(Pro)) of SARS-CoV-2 by Casticin—Insights from Molecular Dynamics Simulations
por: Mensah, Jehoshaphat Oppong, et al.
Publicado: (2022)

Allosteric Binding Sites of the SARS-CoV-2 Main Protease: Potential Targets for Broad-Spectrum Anti-Coronavirus Agents
por: Alzyoud, Lara, et al.
Publicado: (2022)

Molecular modeling evaluation of the binding effect of five protease inhibitors to COVID-19 main protease
por: Liu, Jian, et al.
Publicado: (2021)

Analysis of the efficacy of HIV protease inhibitors against SARS-CoV-2′s main protease
por: Mahdi, Mohamed, et al.
Publicado: (2020)

Inhibitor potency and assay conditions: A case study on SARS-CoV-2 main protease
por: Behnam, Mira A. M., et al.
Publicado: (2021)

Discovery of potent benzoxaborole inhibitors against SARS-CoV-2 main and dengue virus proteases
por: Kühl, Nikos, et al.
Publicado: (2022)

Structural Basis of Main Proteases of Coronavirus Bound to Drug Candidate PF-07304814
por: Li, Jian, et al.
Publicado: (2022)

Crystal structure of SARS-CoV-2 main protease in complex with protease inhibitor PF-07321332
por: Zhao, Yao, et al.
Publicado: (2021)

Insect protease inhibitors; promising inhibitory compounds against SARS-CoV-2 main protease
por: Hemmati, Seyed Ali, et al.
Publicado: (2022)

Biochemical screening for SARS-CoV-2 main protease inhibitors
por: Coelho, Camila, et al.
Publicado: (2020)

Discovery and Mechanism of SARS-CoV-2 Main Protease Inhibitors
por: Huff, Sarah, et al.
Publicado: (2021)

A Warhead Substitution Study on the Coronavirus Main Protease Inhibitor Nirmatrelvir
por: Vankadara, Subramanyam, et al.
Publicado: (2022)

Fullerene derivatives as inhibitors of the SARS-CoV-2 main protease
por: Katagishi, Daiki, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_a1jdtb5kg045fone4dgkaukso5